Safety Study of a Single Dose of Monovalent High-dose Inactivated Poliovirus Type 2 Vaccine (m-IPV2 HD) in Infants Early in Life

NCT02111135 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Polio

Interventions

BIOLOGICAL: b-OPV
BIOLOGICAL: m-OPV2
BIOLOGICAL: m-IPV HD
BIOLOGICAL: t-IPV

Sponsor

Vaxtrials S.A.

Collaborators

[object Object]